nektar therapeutics (NKTR:NASDAQ GS)
Howard W. Robin
Chief Executive Officer, President and Director, Nektar Therapeutics
|Age||Total Calculated Compensation||This person is connected to 74 board members in 3 different organizations across 3 different industries.|
See Board Relationships
As of Fiscal Year 2014
Mr. Howard W. Robin has been the Chief Executive Officer and the President of Prime Holdings & Investments Inc. since July 2001. Mr. Robin has been the Chief Executive Officer and President of Nektar Therapeutics since January 15, 2007. From January 2001 to June 2001, he served as Chief Operating Officer and President of Prime Holdings & Investments Inc. He served as President and Chief Executive Officer of Sirna Therapeutics, Inc. since July 2001. Prior to Sirna Therapeutics, ...
455 Mission Bay Boulevard SouthPhone: 415-482-5300
San Francisco, California 94158
Board Members Memberships*
Director, Member of Compensation Committee, Member of Corporate Governance and Nominating Committee and Member of Research and Development Committee
Chief Executive Officer, President and Director
Fairleigh Dickinson University
|Michael W. Aguiar||Chief Executive Officer, President and Director|
|Peter M. Hecht Ph.D.||Co-Founder, Chief Executive Officer and Director|
Ironwood Pharmaceuticals, Inc.
|James A. Schoeneck||Chief Executive Officer, President and Director|
|Peter S. Greenleaf||Chief Executive Officer and Director|
Sucampo Pharmaceuticals, Inc.
|Daniel J. Abdun-Nabi||Chief Executive Officer, President, Director, Member of Strategic Operations Committee and Member of Pricing Committee|
Emergent BioSolutions, Inc.
|$1.2M||Compensation as of Fiscal Year 2014.|